Trial Profile
A phase 1 clinical trial of ARX-1796
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs ARX-1796 (Primary)
- Indications Gram-negative infections
- Focus Adverse reactions
- 08 May 2018 New trial record
- 01 May 2018 According to an Arixa Pharmaceuticals media release, the company anticipates initiating Phase 1 clinical testing by mid-2019.